Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4231 to 4245 of 7677 results

  1. Lifestyle interventions:- Which components of an intensive lifestyle-change programme contribute most to the effectiveness and cost effectiveness of interventions to prevent or delay type 2 diabetes in those at high risk? How does this vary for different black and minority ethnic groups, for people of different ages for example, aged 18–24, 25–39 and 75 and over, and for vulnerable adults?

    Recommendation ID PH38/4 Question Lifestyle interventions:- Which components of an intensive lifestyle-change programme contribute most

    Research recommendation
    Published
    9 June 2015

  2. What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes?

    Recommendation ID NG238/3 Question What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes

    Research recommendation
    Published
    3 May 2024

  3. What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children with FH?

    Recommendation ID CG71/3 Question What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children

    Research recommendation
    Published
    15 November 2019

  4. Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    Recommendation ID NG78/1 Question Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    Research recommendation
    Published
    18 October 2018

  5. Local coordination:- In the UK, what are the key components of a local coordination role to ensure best value for money in promoting older people's independence and mental wellbeing?

    Recommendation ID NG32/3 Question Local coordination:- In the UK, what are the key components of a local coordination role to ensure best

    Research recommendation
    Published
    25 January 2016

  6. What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?

    Recommendation ID NG123/6 Question What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive

    Research recommendation
    Published
    21 June 2019

  7. What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

    Recommendation ID NG145/2 Question What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for

    Research recommendation
    Published
    10 February 2020

  8. Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken to determine the long-term safety of tenofovir disoproxil, including the risk of clinically significant hypophosphataemia and related bone toxicity, in people with chronic hepatitis B. The cost effectiveness of routine monitoring for phosphate loss and bone disease in people with chronic hepatitis B who are receiving tenofovir disoproxil treatment needs further evaluation.

    Recommendation ID CG165/3 Question Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken

    Research recommendation
    Published
    9 June 2015

  9. Long-term outcomes for children and young people displaying harmful sexual behaviour:- What are the long-term outcomes for children and young people displaying harmful sexual behaviour, when should practitioners intervene and what potentially modifiable factors have the most important impact?

    Recommendation ID NG55/1 Question Long-term outcomes for children and young people displaying harmful sexual behaviour:- What are the long-term

    Research recommendation
    Published
    17 October 2016

  10. Current evidence on the safety and efficacy of low-energy contact X‑ray brachytherapy (the Papillon technique) for locally advanced rectal cancer is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of  research .

    Recommendation ID IPG659/1 Question Current evidence on the safety and efficacy of low-energy contact X‑ray brachytherapy (the Papillon

    Research recommendation
    Published
    15 November 2019

  11. What are the long-term outcomes of different management strategies for primary hyperparathyroidism? Which strategies are most cost effective?

    Recommendation ID NG132/3 Question What are the long-term outcomes of different management strategies for primary hyperparathyroidism?

    Research recommendation
    Published
    25 October 2019

  12. Magnesium sulfate for neuroprotection: bolus plus infusion compared with bolus alone:- What is the clinical effectiveness of a bolus plus infusion of magnesium sulfate compared with a bolus alone for preventing neurodevelopmental injury in babies born preterm?

    Recommendation ID NG25/4 Question Magnesium sulfate for neuroprotection: bolus plus infusion compared with bolus alone:- What is the clinical

    Research recommendation
    Published
    11 December 2015

  13. Long-term real-world data is needed on AposHealth's clinical effectiveness and cost benefit

    Recommendation ID MTG76/1 Question Long-term real-world data is needed on AposHealth's clinical effectiveness and cost benefit Any

    Research recommendation
    Published
    5 May 2023

  14. Maintaining benefits after successful treatment of anorexia nervosa:- What factors (including comorbidities, personal, social and demographic factors, treatment type,and subsequent relapse prevention interventions) are associated with continued benefit after successful treatment for anorexia nervosa?

    Recommendation ID NG69/5 Question Maintaining benefits after successful treatment of anorexia nervosa:- What factors (including comorbidities

    Research recommendation
    Published
    12 October 2018

  15. Long term real-world data is needed on AposHealth's clinical effectiveness and cost benefit

    Recommendation ID MTG76/2 Question Long term real-world data is needed on AposHealth's clinical effectiveness and cost benefit Any

    Research recommendation
    Published
    5 May 2023